Correlation Between SAB Biotherapeutics and Myrexis Cmn
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Myrexis Cmn at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Myrexis Cmn into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and Myrexis Cmn Stk, you can compare the effects of market volatilities on SAB Biotherapeutics and Myrexis Cmn and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Myrexis Cmn. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Myrexis Cmn.
Diversification Opportunities for SAB Biotherapeutics and Myrexis Cmn
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between SAB and Myrexis is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Myrexis Cmn Stk in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Myrexis Cmn Stk and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Myrexis Cmn. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Myrexis Cmn Stk has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Myrexis Cmn go up and down completely randomly.
Pair Corralation between SAB Biotherapeutics and Myrexis Cmn
If you would invest 5.01 in SAB Biotherapeutics on September 13, 2024 and sell it today you would lose (0.01) from holding SAB Biotherapeutics or give up 0.2% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 4.76% |
| Values | Daily Returns |
SAB Biotherapeutics vs. Myrexis Cmn Stk
Performance |
| Timeline |
| SAB Biotherapeutics |
| Myrexis Cmn Stk |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
SAB Biotherapeutics and Myrexis Cmn Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with SAB Biotherapeutics and Myrexis Cmn
The main advantage of trading using opposite SAB Biotherapeutics and Myrexis Cmn positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Myrexis Cmn can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Myrexis Cmn will offset losses from the drop in Myrexis Cmn's long position.| SAB Biotherapeutics vs. SAB Biotherapeutics | SAB Biotherapeutics vs. Jasper Therapeutics | SAB Biotherapeutics vs. NRx Pharmaceuticals | SAB Biotherapeutics vs. Surrozen Warrant |
| Myrexis Cmn vs. UMAX Group Corp | Myrexis Cmn vs. AlphaTime Acquisition Corp | Myrexis Cmn vs. Manaris Corp | Myrexis Cmn vs. Alpha One |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |